Drug Type Small molecule drug |
Synonyms F06-C40, SLI F06 |
Target |
Action modulators |
Mechanism Collagen modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cicatrix | Phase 2 | United States | 25 Jul 2022 | |
| Wounds and Injuries | Phase 2 | United States | 25 Jul 2022 |
Phase 1/2 | 22 | (SLI-F06) | nefjprgdxk(heuzqifzdu) = aaxnatlgrw sdztawlyqr (adlwfbvfkg, 1.7) View more | - | 18 Apr 2023 | ||
Formulation buffer (Formulation Buffer) | nefjprgdxk(heuzqifzdu) = rmyjijqdui sdztawlyqr (adlwfbvfkg, 1.7) View more |





